SENATE BILL 6086
State of Washington
2020 Regular Session
BySenators Hasegawa, Keiser, Kuderer, and Nguyen
Prefiled 12/18/19.Read first time 01/13/20.Referred to Committee on Health & Long Term Care.
AN ACT Relating to increasing access to medications for people with opioid use disorder; and amending RCW 18.64.450
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
and 2013 c 19 s 26 are each amended to read as follows:
(1) In order for a health care entity to purchase, administer, dispense, and deliver legend drugs, the health care entity must be licensed by the department.
(2) In order for a health care entity to purchase, administer, dispense, and deliver controlled substances, the health care entity must annually obtain a license from the department in accordance with the commission's rules.
(3) The receipt, administration, dispensing, and delivery of legend drugs or controlled substances by a health care entity must be performed under the supervision or at the direction of a pharmacist.
(4) ((A))Except as provided in subsection (5) of this section, a health care entity may only administer, dispense, or deliver up to a seventy-two hour supply of legend drugs and controlled substances to patients who receive care within the health care entity and in compliance with rules of the commission. ((Nothing in this subsection shall prohibit a practitioner, in carrying out his or her licensed responsibilities within a health care entity, from dispensing or delivering to a patient of the health care entity drugs for that patient's personal use in an amount not to exceed seventy-two hours of usage.))
(5) A health care entity may only administer, dispense, or deliver up to a two-week supply of legend drugs and controlled substances to patients who receive evidence-based opioid use disorder treatment at the health care entity and in compliance with rules of the commission.
--- END ---